Findings highlight the Pfizer ... vaccine’s role in preventing MIS-C, a rare post-COVID inflammatory syndrome in children.

Unverified data about events after vaccinations is not evidence that the vaccine caused the event, as suggested in social ...

In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three ...

On Tuesday, the FDA approved Pfizer Inc’s (NYSE:PFE) Abrysvo (Respiratory Syncytial Virus Vaccine), the company’s bivalent RSV prefusion F (RSVpreF) vaccine, to prevent lower respiratory tract ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the fall and winter seasons. Here we answer common questions about the latest ...

NEW YORK, October 22, 2024--(BUSINESS WIRE)--Pfizer Inc. (NYSE ... approved ABRYSVO ® (Respiratory Syncytial Virus Vaccine), the company’s bivalent RSV prefusion F (RSVpreF) vaccine, for ...

Barely three years ago, Pfizer was the toast of the pharmaceutical world and Bourla, who was elevated to the top job in 2019, wrote a book about the race to develop the coronavirus vaccine.

Although Merck’s vaccine, like Pfizer’s, is approved for use in people at least 18 years of age, Capvaxive is the only pneumococcal disease vaccine that was specifically made to protect adults ...

The Food and Drug Administration expanded its approval of Pfizer’s vaccine for a deadly respiratory virus to a new age group. The vaccine, called Abrysvo, has been approved for the prevention of ...

The company also has promising candidates in immunology, rare diseases, and vaccines. This diverse pipeline provides multiple opportunities for future growth. Pfizer faces near-term challenges as ...

Oct 22 (Reuters) - The U.S. Food and Drug Administration on Tuesday approved Pfizer's (PFE.N), opens new tab RSV vaccine for the prevention of lower respiratory tract disease caused by RSV in ...

VSD also identified a signal for ischemic stroke for both mRNA vaccines, but the findings were not consistent. Previously, VSD identified a statistical signal for the Pfizer/BioNTech bivalent ...